{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1380298345304985088.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Shashank Ghantoji"}],"foaf:familyName":[{"@value":"Ghantoji"}],"foaf:givenName":[{"@value":"Shashank"}]}],"career":[{"institution":{"notation":[{"@value":"Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston"}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1360298345304985088","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1093/cid/ciy760"},{"@type":"URI","@value":"http://academic.oup.com/cid/article-pdf/68/10/1641/28543444/ciy760.pdf"}],"notation":[{"@value":"Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1093/cid/ciy760_AZgs3v9ls0JPLdRVwpXLkAoxR2f"}]}